Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKIShow others and affiliations
2021 (English)In: Leukemia, ISSN 0887-6924, E-ISSN 1476-5551, Vol. 35, no 8, p. 2416-2418Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Springer, 2021. Vol. 35, no 8, p. 2416-2418
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-89665DOI: 10.1038/s41375-021-01173-wISI: 000618175800004PubMedID: 33589755Scopus ID: 2-s2.0-85106311624OAI: oai:DiVA.org:oru-89665DiVA, id: diva2:1529005
Note
Funding Agencies:
Lund University
Skåne University Hospital
2021-02-172021-02-172021-08-16Bibliographically approved